
MODIA™ is being tested in a pivotal study
Large pivotal study initiated in June 2021, where the efficacy of MODIA™ is evaluated along with bup/nal pharma treatment.
Orexo´s digital therapies deliver therapeutic interventions to patients to prevent, manage, or treat a medical disorder or disease. The therapies are available for patients in their own privacy 24/7 and can be used as a standalone treatment or together with traditional drugs. Its efficacy has been demonstrated in numerous published clinical trials including thousands of patients.
The therapies are developed based on established cognitive-behavioral therapy technique which is a goal-oriented psychotherapy treatment that takes a hands-on, practical approach to problem-solving. The aim is to provide support and change patterns of thinking or behavior that are behind patients difficulties.
Large pivotal study initiated in June 2021, where the efficacy of MODIA™ is evaluated along with bup/nal pharma treatment.
Our digital therapies are fully automated developed by GAIA and based on its proprietary artificial intelligence (AI)-expert system, broca®.
Deprexis® effectiveness in managing the symptoms of depression has been evaluated and published in 11 randomized clinical trials (RCTs) including more than 2,800 patients.